๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cancer Immune Therapy || Hybrid Cell Vaccination for Cancer Immune Therapy

โœ Scribed by Stuhler, Gernot; Walden, Peter

Publisher
Wiley
Year
2002
Tongue
German
Weight
169 KB
Volume
10.1002/3527600795
Category
Article
ISBN
3527600795

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hybrid cell vaccination for cancer immun
Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma
โœ Uwe Trefzer; Guido Weingart; Yingwen Chen; Gunda Herberth; Karin Adrian; Helmut ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 364 KB ๐Ÿ‘ 1 views

Hybrid cell vaccination is a new cancer immune therapy approach that aims at recruiting T cell help for the induction of tumour specific cytolytic immunity. The vaccines are generated by fusion of the patients' tumour cells with allogeneic MHC class II bearing cells to combine the tumour's antigenic

Cancer Immune Therapy || Glossary
Cancer Immune Therapy || Glossary
โœ Stuhler, Gernot; Walden, Peter ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Wiley ๐ŸŒ German โš– 103 KB

a 2 -Macroglobulin A serum protease inhibitor with a broad range of specificities which blocks members of all four known classes of endopeptidases. It contains a unique thiol ester group which, when cleaved by the proteases, results in a covalent bond between protease and inhibitor. Concordantly, th